John F. Neylan
2015
In 2015, John F. Neylan earned a total compensation of $1.6M as Chief Medical Officer at Keryx Biopharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $49,900 |
|---|---|
| Option Awards | $769,140 |
| Salary | $266,154 |
| Stock Awards | $518,400 |
| Total | $1,603,594 |
Neylan received $769.1K in option awards, accounting for 48% of the total pay in 2015.
Neylan also received $49.9K in non-equity incentive plan, $266.2K in salary and $518.4K in stock awards.
Rankings
In 2015, John F. Neylan's compensation ranked 5,661st out of 13,638 executives tracked by ExecPay. In other words, Neylan earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,661 out of 13,638 | 59th |
Division Manufacturing | 2,106 out of 5,190 | 59th |
Major group Chemicals And Allied Products | 760 out of 1,854 | 59th |
Industry group Drugs | 603 out of 1,528 | 61st |
Industry Pharmaceutical Preparations | 472 out of 1,182 | 60th |
Source: SEC filing on April 26, 2017.
Neylan's colleagues
We found five more compensation records of executives who worked with John F. Neylan at Keryx Biopharmaceuticals in 2015.
2015
Gregory Madison
Keryx Biopharmaceuticals
Chief Executive Officer
2015
Ron Bentsur
Keryx Biopharmaceuticals
Chief Executive Officer
2015
James Oliviero
Keryx Biopharmaceuticals
Chief Financial Officer
2015
Brian Adams
Keryx Biopharmaceuticals
General Counsel
2015
Scott Holmes
Keryx Biopharmaceuticals